SHINE to Build Facility in Europe
SHINE Medical Technologies will build its European medical isotope production facility in the Netherlands, the company announced today. According to a release, the European facility, which will be located in…
Tag Archives: SHINE Medical Technologies
SHINE, Phoenix Merge
SHINE Medical Technologies and Phoenix have completed a merger under which Phoenix has become a wholly owned subsidiary of SHINE, the companies announced today. “SHINE and Phoenix have shared a…
SHINE Announces Weathertight Facility, Board Members
SHINE Medical Technologies has completed exterior construction of its medical isotope production facility and made it weathertight for protection, the company announced today. According to a release, the facility can withstand…
SHINE Breaks Ground on HQ
SHINE Medical Technologies broke ground on its 54,000-square-foot corporate headquarters and therapeutics production facility in Janesville, Wis., the company announced recently. “The best work we do at SHINE is the…
SHINE to Add a Supercell to Facility
SHINE Medical Technologies will add a “supercell,” a bank of 10 hot cells, for its medical isotope production facility in Janesville, Wis., the company announced recently. According to a release,…
SHINE Makes First Sale of Lu-177 Isotope
SHINE Medical Technologies Therapeutics division has made its first commercial sale of lutetium-177, a therapeutic isotope in demand by clinical trial sponsors, the company announced recently. “This milestone is really exciting,…
SHINE Closes $80M Series C
SHINE Medical Technologies has closed an $80 million Series C financing round, the company announced recently. “This funding round will help SHINE’s continuing efforts to commercialize vital diagnostic and therapeutic…
NRC to Decide on SHINE Operating License by 2021
The U.S. Nuclear Regulatory Commission (NRC) expects to make a final determination regarding the issuance of an operating license to SHINE Medical Technologies by October 2021, the company announced today….
SHINE, IOCB Announce Production of Lu-177
SHINE Medical Technologies, the Institute of Organic Chemistry and Biochemistry (IOCB Prague) and GE Healthcare announced today the production of patient-dose quantities of the therapeutic isotope lutetium-177 (Lu-177). According to…
SHINE Recaps 2019 Achievements
SHINE Medical Technologies recently announced its 2019 year-end report, which included updates on its construction progress, continued investor support, its new therapeutics division and information about commercial and regulatory news….
